Comparison of Pre-hospital and In-hospital Iv-tPA Stroke Treatment
1 other identifier
observational
658
1 country
1
Brief Summary
This is a comparison of clinical outcomes between a pre-hospital and an in-hospital thrombolysis patient registry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2011
CompletedFirst Submitted
Initial submission to the registry
February 4, 2015
CompletedFirst Posted
Study publicly available on registry
February 9, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedAugust 10, 2016
August 1, 2016
4.3 years
February 4, 2015
August 8, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
modified Rankin Scale (mRS) score
dichotomized mRS 0-1 and 2-6 in patients who lived at home without assistance prior to the index stroke.
three months after event
Secondary Outcomes (3)
modified Rankin Scale (mRS) score
three months after event
modified Rankin Scale (mRS) score
three months after event
modified Rankin Scale (mRS) score
three months after event
Study Arms (2)
Pre-hospital thrombolysis
Patients with acute ischemic stroke who are cared in a specialized STroke Emergency MObile (STEMO) before admission to the Hospital and receive thrombolytic therapy (either in STEMO or in Hospital).
In-hospital thrombolysis
Patients with acute ischemic stroke who receive thrombolytic therapy after admission to an University Hospital.
Interventions
Eligibility Criteria
acute ischemic stroke patients with thrombolytic treatment
You may qualify if:
- Acute ischemic stroke diagnosis with thrombolytic treatment
- Admission via EMS
- Known premorbid status of need of assistance
- NIHSS before treatment available
- Time of onset (or last well seen) between 4:00am and 10:30pm
You may not qualify if:
- Unknown time of onset
- In-hospital thrombolysis despite decision against treatment because of contraindications in STEMO
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charité
Berlin, State of Berlin, 10117, Germany
Related Publications (3)
Ebinger M, Winter B, Wendt M, Weber JE, Waldschmidt C, Rozanski M, Kunz A, Koch P, Kellner PA, Gierhake D, Villringer K, Fiebach JB, Grittner U, Hartmann A, Mackert BM, Endres M, Audebert HJ; STEMO Consortium. Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial. JAMA. 2014 Apr 23-30;311(16):1622-31. doi: 10.1001/jama.2014.2850.
PMID: 24756512BACKGROUNDKunz A, Ebinger M, Geisler F, Rozanski M, Waldschmidt C, Weber JE, Wendt M, Winter B, Zieschang K, Fiebach JB, Villringer K, Erdur H, Scheitz JF, Tutuncu S, Bollweg K, Grittner U, Kaczmarek S, Endres M, Nolte CH, Audebert HJ. Functional outcomes of pre-hospital thrombolysis in a mobile stroke treatment unit compared with conventional care: an observational registry study. Lancet Neurol. 2016 Sep;15(10):1035-43. doi: 10.1016/S1474-4422(16)30129-6. Epub 2016 Jul 16.
PMID: 27430529BACKGROUNDNolte CH, Ebinger M, Scheitz JF, Kunz A, Erdur H, Geisler F, Braemswig TB, Rozanski M, Weber JE, Wendt M, Zieschang K, Fiebach JB, Villringer K, Grittner U, Kaczmarek S, Endres M, Audebert HJ. Effects of Prehospital Thrombolysis in Stroke Patients With Prestroke Dependency. Stroke. 2018 Mar;49(3):646-651. doi: 10.1161/STROKEAHA.117.019060. Epub 2018 Feb 19.
PMID: 29459395DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heinrich J Audebert, MD
Center for Stroke Research Berlin, Charité Universitätsmedizin Berlin
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. med.
Study Record Dates
First Submitted
February 4, 2015
First Posted
February 9, 2015
Study Start
February 1, 2011
Primary Completion
June 1, 2015
Study Completion
July 1, 2016
Last Updated
August 10, 2016
Record last verified: 2016-08